Disclosure Of Intangible Assets [Text Block]

Innate Pharma - Filing #2821023

Concept As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
46 289 EUR
96 968 EUR
Changes in intangible assets other than goodwill [abstract]
Impairment loss recognised in profit or loss, intangible assets other than goodwill
43 529 EUR
EUR
Research and development expense
58 613 EUR
78 844 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.